{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:29:35Z","timestamp":1780093775552,"version":"3.54.0"},"reference-count":198,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"CONICET (Consejo Nacional de Investigaciones Cient\u00edficas y Tecnol\u00f3gicas)"},{"name":"Facultad de Farmacia y Bioqu\u00edmica, Universidad de Buenos Aires"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biotechnology Advances"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.biotechadv.2012.03.004","type":"journal-article","created":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T02:51:04Z","timestamp":1332903064000},"page":"1493-1505","source":"Crossref","is-referenced-by-count":15,"title":["Research advances in plant-made flavivirus antigens"],"prefix":"10.1016","volume":"30","author":[{"given":"C.A.","family":"Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Giulietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Rodr\u00edguez Talou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.biotechadv.2012.03.004_bb0005","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.vaccine.2010.12.081","article-title":"Recombinant West Nile virus envelope protein E and domain III expressed in insect larvae protects mice against West Nile disease","volume":"29","author":"Alonso-Padilla","year":"2011","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.biotechadv.2012.03.004_bb0015","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1586\/erv.10.139","article-title":"IMOJEV: a Yellow fever virus-based novel Japanese encephalitis vaccine","volume":"9","author":"Appaiahgari","year":"2010","journal-title":"Expert Rev Vaccines"},{"issue":"1\u20132","key":"10.1016\/j.biotechadv.2012.03.004_bb0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jviromet.2009.07.002","article-title":"Expression of Japanese encephalitis virus envelope protein in transgenic tobacco plants","volume":"162","author":"Appaiahgari","year":"2009","journal-title":"J Virol Methods"},{"issue":"22","key":"10.1016\/j.biotechadv.2012.03.004_bb0020","doi-asserted-by":"crossref","first-page":"12497","DOI":"10.1128\/JVI.78.22.12497-12507.2004","article-title":"ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy","volume":"78","author":"Arroyo","year":"2004","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.biotechadv.2012.03.004_bb0025","doi-asserted-by":"crossref","first-page":"e4792","DOI":"10.1371\/journal.pone.0004792","article-title":"A plant-derived recombinant human glucocerebrosidase enzyme\u2014a preclinical and phase I investigation","volume":"4","author":"Aviezer","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.biotechadv.2012.03.004_bb0030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/1743-422X-8-261","article-title":"Yellow fever virus envelope protein expressed in insect cells is capable of syncytium formation in lepidopteran cells and could be used for immunodetection of YFV in human sera","volume":"8","author":"Barros","year":"2011","journal-title":"Virol J"},{"issue":"24","key":"10.1016\/j.biotechadv.2012.03.004_bb0035","doi-asserted-by":"crossref","first-page":"13097","DOI":"10.1128\/JVI.76.24.13097-13100.2002","article-title":"Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein","volume":"76","author":"Beasley","year":"2002","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.biotechadv.2012.03.004_bb0040","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.vaccine.2010.11.050","article-title":"Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial","volume":"29","author":"Beckett","year":"2011","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.biotechadv.2012.03.004_bb0045","doi-asserted-by":"crossref","first-page":"9211","DOI":"10.1128\/JVI.77.17.9211-9220.2003","article-title":"Production of human papillomavirus type 16 virus-like particles in transgenic plants","volume":"77","author":"Biemelt","year":"2003","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.biotechadv.2012.03.004_bb0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0168-1656(02)00181-5","article-title":"Recombinant dengue virus type 2 envelope\/hepatitis B surface antigen hybrid protein expressed in Pichia pastoris can function as a bivalent immunogen","volume":"99","author":"Bisht","year":"2002","journal-title":"J Biotechnol"},{"issue":"2","key":"10.1016\/j.biotechadv.2012.03.004_bb0055","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.vaccine.2008.10.046","article-title":"A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells","volume":"27","author":"Bonafe","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2012.03.004_bb2020","first-page":"1","article-title":"Epidemic\/Epizootic West Nile Virus in the United States: Guidelines for Surveillance, Prevention, and Control","author":"CDC","year":"2003","journal-title":"3rd Revision"},{"issue":"9276","key":"10.1016\/j.biotechadv.2012.03.004_bb0080","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(01)05341-7","article-title":"Hepatitis and death following vaccination with 17D-204 yellow fever vaccine","volume":"358","author":"Chan","year":"2001","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.biotechadv.2012.03.004_bb0085","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nbt1400","article-title":"Single-round infectious particles enhance immunogenicity of a DNA vaccine against West Nile virus","volume":"26","author":"Chang","year":"2008","journal-title":"Nat Biotechnol"},{"issue":"5","key":"10.1016\/j.biotechadv.2012.03.004_bb0090","first-page":"639","article-title":"Dengue vaccines: problems and prospects","volume":"121","author":"Chaturvedi","year":"2005","journal-title":"Indian J Med Res"},{"issue":"6","key":"10.1016\/j.biotechadv.2012.03.004_bb0095","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.biologicals.2010.07.004","article-title":"Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization","volume":"38","author":"Chavez","year":"2010","journal-title":"Biologicals"},{"issue":"3","key":"10.1016\/j.biotechadv.2012.03.004_bb0100","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4161\/hv.7.3.14262","article-title":"Geminiviral vectors based on bean yellow dwarf virus for production of vaccine antigens and monoclonal antibodies in plants","volume":"7","author":"Chen","year":"2011","journal-title":"Hum Vaccin"},{"issue":"5","key":"10.1016\/j.biotechadv.2012.03.004_bb0105","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.4049\/jimmunol.178.5.2699","article-title":"Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection","volume":"178","author":"Chu","year":"2007","journal-title":"J Immunol"},{"issue":"15","key":"10.1016\/j.biotechadv.2012.03.004_bb0060","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/j.vaccine.2010.01.022","article-title":"Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys","volume":"28","author":"Clements","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.biotechadv.2012.03.004_bb0065","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.coi.2011.03.005","article-title":"Dengue vaccines: progress and challenges","volume":"23","author":"Coller","year":"2011","journal-title":"Curr Opin Immunol"},{"issue":"42","key":"10.1016\/j.biotechadv.2012.03.004_bb0070","doi-asserted-by":"crossref","first-page":"7267","DOI":"10.1016\/j.vaccine.2011.07.021","article-title":"The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease","volume":"29","author":"Coller","year":"2011","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.biotechadv.2012.03.004_bb0075","doi-asserted-by":"crossref","first-page":"13975","DOI":"10.1128\/JVI.78.24.13975-13986.2004","article-title":"Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes","volume":"78","author":"Crill","year":"2004","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.biotechadv.2012.03.004_bb0115","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.tplants.2009.09.009","article-title":"Plant-made vaccine antigens and biopharmaceuticals","volume":"14","author":"Daniell","year":"2009","journal-title":"Trends Plant Sci"},{"issue":"5","key":"10.1016\/j.biotechadv.2012.03.004_bb0110","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1467-7652.2009.00496.x","article-title":"The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza","volume":"8","author":"D'Aoust","year":"2010","journal-title":"Plant Biotechnol J"},{"issue":"30","key":"10.1016\/j.biotechadv.2012.03.004_bb0120","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1016\/j.vaccine.2006.12.005","article-title":"West Nile virus: recent trends in diagnosis and vaccine development","volume":"25","author":"Dauphin","year":"2007","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.biotechadv.2012.03.004_bb0125","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1467-7652.2010.00550.x","article-title":"Review article: commercialization of whole-plant systems for biomanufacturing of protein products: evolution and prospects","volume":"8","author":"Davies","year":"2010","journal-title":"Plant Biotechnol J"},{"issue":"9","key":"10.1016\/j.biotechadv.2012.03.004_bb0130","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1128\/JVI.75.9.4040-4047.2001","article-title":"West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays","volume":"75","author":"Davis","year":"2001","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.biotechadv.2012.03.004_bb0135","doi-asserted-by":"crossref","first-page":"488","DOI":"10.4161\/hv.8247","article-title":"The green vaccine: a global strategy to combat infectious and autoimmune diseases","volume":"5","author":"Davoodi-Semiromi","year":"2009","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.biotechadv.2012.03.004_bb0975","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11240-010-9690-z","article-title":"Overexpression and characterization of cyprosin B in transformed suspension cells of Cynara cardunculus","volume":"101","author":"de Sousa Sampaio","year":"2010","journal-title":"Plant Cell Tissue Organ Cult"},{"issue":"Pt 11","key":"10.1016\/j.biotechadv.2012.03.004_bb0155","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1099\/0022-1317-72-11-2811","article-title":"Recombinant baculoviruses expressing yellow fever virus E and NS1 proteins elicit protective immunity in mice","volume":"72","author":"Despres","year":"1991","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.biotechadv.2012.03.004_bb0150","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1086\/426824","article-title":"Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis","volume":"191","author":"Despres","year":"2005","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.biotechadv.2012.03.004_bb0160","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1440-1711.2003.01157.x","article-title":"Evasion of innate and adaptive immunity by flaviviruses","volume":"81","author":"Diamond","year":"2003","journal-title":"Immunol Cell Biol"},{"issue":"4","key":"10.1016\/j.biotechadv.2012.03.004_bb0165","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1128\/JVI.77.4.2578-2586.2003","article-title":"B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus","volume":"77","author":"Diamond","year":"2003","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.biotechadv.2012.03.004_bb0170","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00003495-200969010-00008","article-title":"Japanese encephalitis vaccine (inactivated, adsorbed) [IXIARO]","volume":"69","author":"Duggan","year":"2009","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.biotechadv.2012.03.004_bb0175","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4161\/hv.2.6.3494","article-title":"rDEN2\/4Delta30(ME), a live attenuated chimeric dengue serotype 2 vaccine is safe and highly immunogenic in healthy dengue-naive adults","volume":"2","author":"Durbin","year":"2006","journal-title":"Hum Vaccin"},{"issue":"4","key":"10.1016\/j.biotechadv.2012.03.004_bb0180","doi-asserted-by":"crossref","first-page":"472","DOI":"10.4269\/ajtmh.1994.50.472","article-title":"Immunization of monkeys with baculovirus-dengue type-4 recombinants containing envelope and nonstructural proteins: evidence of priming and partial protection","volume":"50","author":"Eckels","year":"1994","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.biotechadv.2012.03.004_bb0185","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1467-7652.2010.00521.x","article-title":"Success stories in molecular farming\u2014a brief overview","volume":"8","author":"Faye","year":"2010","journal-title":"Plant Biotechnol J"},{"issue":"4","key":"10.1016\/j.biotechadv.2012.03.004_bb0190","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.1992.47.405","article-title":"Purification of native dengue-2 viral proteins and the ability of purified proteins to protect mice","volume":"47","author":"Feighny","year":"1992","journal-title":"Am J Trop Med Hyg"},{"issue":"RR-1","key":"10.1016\/j.biotechadv.2012.03.004_bb0980","first-page":"1","article-title":"Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Fischer","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"10.1016\/j.biotechadv.2012.03.004_bb0200","first-page":"303","article-title":"Studies in the development of Japanese encephalitis vaccine: expression of virus envelope glycoprotein V3 (E) gene in yeast","volume":"65","author":"Fujita","year":"1987","journal-title":"Bull World Health Organ"},{"issue":"3","key":"10.1016\/j.biotechadv.2012.03.004_bb0205","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1286-4579(01)01374-0","article-title":"The West Nile virus: its recent emergence in North America","volume":"3","author":"Garmendia","year":"2001","journal-title":"Microbes Infect"},{"issue":"9","key":"10.1016\/j.biotechadv.2012.03.004_bb0985","doi-asserted-by":"crossref","first-page":"e437","DOI":"10.1371\/journal.pntd.0000437","article-title":"Japanese encephalitis\u2014a pathological and clinical perspective","volume":"3","author":"Ghosh","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"issue":"17\u201318","key":"10.1016\/j.biotechadv.2012.03.004_bb0215","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/j.vaccine.2005.01.006","article-title":"Magnifection\u2014a new platform for expressing recombinant vaccines in plants","volume":"23","author":"Gleba","year":"2005","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.biotechadv.2012.03.004_bb0220","doi-asserted-by":"crossref","first-page":"9422","DOI":"10.1073\/pnas.0703498104","article-title":"Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention","volume":"104","author":"Goncalvez","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13\u201314","key":"10.1016\/j.biotechadv.2012.03.004_bb0225","first-page":"630","article-title":"A study of systems for delivering antigens and plasmid DNA for intranasal immunization against tick-borne encephalitis virus","volume":"114","author":"Goncharova","year":"2002","journal-title":"Wien Klin Wochenschr"},{"issue":"23","key":"10.1016\/j.biotechadv.2012.03.004_bb0230","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/j.vaccine.2004.11.068","article-title":"Role of the N-linked glycans of the prM and E envelope proteins in tick-borne encephalitis virus particle secretion","volume":"23","author":"Goto","year":"2005","journal-title":"Vaccine"},{"issue":"9611","key":"10.1016\/j.biotechadv.2012.03.004_bb0235","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0140-6736(08)60238-X","article-title":"Pathogenic flaviviruses","volume":"371","author":"Gould","year":"2008","journal-title":"Lancet"},{"issue":"46","key":"10.1016\/j.biotechadv.2012.03.004_bb0240","doi-asserted-by":"crossref","first-page":"7396","DOI":"10.1016\/j.vaccine.2010.09.003","article-title":"Tick-borne encephalitis after vaccination: vaccine failure or misdiagnosis","volume":"28","author":"Grgic-Vitek","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.biotechadv.2012.03.004_bb0245","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1128\/CMR.11.3.480","article-title":"Dengue and dengue hemorrhagic fever","volume":"11","author":"Gubler","year":"1998","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1016\/j.biotechadv.2012.03.004_bb0255","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.vaccine.2009.09.098","article-title":"Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses","volume":"28","author":"Guy","year":"2010","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.biotechadv.2012.03.004_bb0990","doi-asserted-by":"crossref","DOI":"10.4161\/hv.6.9.12739","article-title":"Development of Sanofi Pasteur tetravalent dengue vaccine","volume":"6","author":"Guy","year":"2010","journal-title":"Hum Vaccin"},{"issue":"42","key":"10.1016\/j.biotechadv.2012.03.004_bb0250","doi-asserted-by":"crossref","first-page":"7229","DOI":"10.1016\/j.vaccine.2011.06.094","article-title":"From research to phase III: Preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine","volume":"29","author":"Guy","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.biotechadv.2012.03.004_bb0265","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3201\/eid1302.060539","article-title":"Neutralizing antibodies after infection with dengue 1 virus","volume":"13","author":"Guzman","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.biotechadv.2012.03.004_bb0270","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1586\/erv.09.139","article-title":"Domain III of the envelope protein as a dengue vaccine target","volume":"9","author":"Guzman","year":"2010","journal-title":"Expert Rev Vaccines"},{"issue":"9599","key":"10.1016\/j.biotechadv.2012.03.004_bb0275","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(07)61687-0","article-title":"Dengue","volume":"370","author":"Halstead","year":"2007","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.biotechadv.2012.03.004_bb0280","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3201\/eid1108.050289a","article-title":"Epidemiology and transmission dynamics of West Nile virus disease","volume":"11","author":"Hayes","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.biotechadv.2012.03.004_bb0285","doi-asserted-by":"crossref","first-page":"106783","DOI":"10.1155\/2012\/106783","article-title":"A novel system for rapid and cost-effective production of detection and diagnostic reagents of West Nile virus in plants","volume":"2012","author":"He","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.biotechadv.2012.03.004_bb2015","series-title":"Virus taxonomy","article-title":"Family flaviviridae","author":"Heinz","year":"2000"},{"issue":"11","key":"10.1016\/j.biotechadv.2012.03.004_bb0290","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/nbt1027","article-title":"Plant cell cultures for the production of recombinant proteins","volume":"22","author":"Hellwig","year":"2004","journal-title":"Nat Biotechnol"},{"issue":"3","key":"10.1016\/j.biotechadv.2012.03.004_bb0295","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1586\/erv.09.163","article-title":"Norwalk virus-like particles as vaccines","volume":"9","author":"Herbst-Kralovetz","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"9","key":"10.1016\/j.biotechadv.2012.03.004_bb0300","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1128\/JCM.42.9.4101-4110.2004","article-title":"Use of recombinant E protein domain III-based enzyme-linked immunosorbent assays for differentiation of tick-borne encephalitis serocomplex flaviviruses from mosquito-borne flaviviruses","volume":"42","author":"Holbrook","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"21","key":"10.1016\/j.biotechadv.2012.03.004_bb0305","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/j.vaccine.2004.11.040","article-title":"Review on flavivirus vaccine development. Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26\u201327 April 2004, Bangkok, Thailand","volume":"23","author":"Hombach","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2012.03.004_bb0315","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bej.2009.02.008","article-title":"Bioreactor engineering for recombinant protein production in plant cell suspension cultures","volume":"45","author":"Huang","year":"2009","journal-title":"Biochem Eng J"},{"issue":"21","key":"10.1016\/j.biotechadv.2012.03.004_bb0310","doi-asserted-by":"crossref","first-page":"11436","DOI":"10.1128\/JVI.77.21.11436-11447.2003","article-title":"Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development","volume":"77","author":"Huang","year":"2003","journal-title":"J Virol"},{"issue":"15","key":"10.1016\/j.biotechadv.2012.03.004_bb0325","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.vaccine.2004.11.017","article-title":"Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses","volume":"23","author":"Huang","year":"2005","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.biotechadv.2012.03.004_bb0330","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.vaccine.2005.12.024","article-title":"Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice","volume":"24","author":"Huang","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.biotechadv.2012.03.004_bb0320","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/bit.22299","article-title":"A DNA replicon system for rapid high-level production of virus-like particles in plants","volume":"103","author":"Huang","year":"2009","journal-title":"Biotechnol Bioeng"},{"issue":"3","key":"10.1016\/j.biotechadv.2012.03.004_bb0335","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jgm.837","article-title":"A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus","volume":"8","author":"Iglesias","year":"2006","journal-title":"J Gene Med"},{"issue":"43","key":"10.1016\/j.biotechadv.2012.03.004_bb0340","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1016\/j.vaccine.2011.07.058","article-title":"Enhancing the utility of a prM\/E-expressing chimeric vaccine for Japanese encephalitis by addition of the JEV NS1 gene","volume":"29","author":"Ishikawa","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.biotechadv.2012.03.004_bb0345","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pep.2003.09.009","article-title":"High-level expression and one-step purification of recombinant dengue virus type 2 envelope domain III protein in Escherichia coli","volume":"33","author":"Jaiswal","year":"2004","journal-title":"Protein Expr Purif"},{"issue":"Pt 11","key":"10.1016\/j.biotechadv.2012.03.004_bb0355","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1093\/brain\/122.11.2067","article-title":"The clinical and epidemiological profile of tick-borne encephalitis in southern Germany 1994\u201398: a prospective study of 656 patients","volume":"122","author":"Kaiser","year":"1999","journal-title":"Brain"},{"issue":"5875","key":"10.1016\/j.biotechadv.2012.03.004_bb0350","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.320.5875.473","article-title":"Is the drought over for pharming?","volume":"320","author":"Kaiser","year":"2008","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.biotechadv.2012.03.004_bb0360","first-page":"378","article-title":"Is dengue severity related to nutritional status?","volume":"36","author":"Kalayanarooj","year":"2005","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"3\u20135","key":"10.1016\/j.biotechadv.2012.03.004_bb0365","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11103-011-9766-0","article-title":"Expression of dengue-3 premembrane and envelope polyprotein in lettuce chloroplasts","volume":"76","author":"Kanagaraj","year":"2011","journal-title":"Plant Mol Biol"},{"issue":"23\u201324","key":"10.1016\/j.biotechadv.2012.03.004_bb0370","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1016\/S0264-410X(01)00020-2","article-title":"Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers","volume":"19","author":"Kanesa-thasan","year":"2001","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.biotechadv.2012.03.004_bb0375","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/S0264-410X(00)00032-3","article-title":"Purified dengue 2 virus envelope glycoprotein aggregates produced by baculovirus are immunogenic in mice","volume":"18","author":"Kelly","year":"2000","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.biotechadv.2012.03.004_bb0380","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.pep.2010.07.013","article-title":"Cholera toxin B subunit-domain III of dengue virus envelope glycoprotein E fusion protein production in transgenic plants","volume":"74","author":"Kim","year":"2010","journal-title":"Protein Expr Purif"},{"issue":"1","key":"10.1016\/j.biotechadv.2012.03.004_bb0385","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.icb.7100012","article-title":"Immunopathology of flavivirus infections","volume":"85","author":"King","year":"2007","journal-title":"Immunol Cell Biol"},{"issue":"2","key":"10.1016\/j.biotechadv.2012.03.004_bb0390","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4269\/ajtmh.1988.38.411","article-title":"Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants","volume":"38","author":"Kliks","year":"1988","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.biotechadv.2012.03.004_bb0395","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0264-410X(97)00215-6","article-title":"Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice","volume":"15","author":"Kochel","year":"1997","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.biotechadv.2012.03.004_bb0400","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1128\/JVI.76.7.3534-3543.2002","article-title":"Capsid protein C of tick-borne encephalitis virus tolerates large internal deletions and is a favorable target for attenuation of virulence","volume":"76","author":"Kofler","year":"2002","journal-title":"J Virol"},{"issue":"7\u20138","key":"10.1016\/j.biotechadv.2012.03.004_bb0405","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0264-410X(01)00446-7","article-title":"Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine","volume":"20","author":"Konishi","year":"2002","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.biotechadv.2012.03.004_bb0410","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1128\/JVI.75.5.2204-2212.2001","article-title":"Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles","volume":"75","author":"Konishi","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.biotechadv.2012.03.004_bb0415","doi-asserted-by":"crossref","first-page":"864029","DOI":"10.1155\/2010\/864029","article-title":"Bioinformatics in new generation flavivirus vaccines","volume":"2010","author":"Koraka","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.biotechadv.2012.03.004_bb0420","first-page":"321","article-title":"Clinical features & prognostic indicators of Japanese encephalitis in children in Lucknow (India)","volume":"91","author":"Kumar","year":"1990","journal-title":"Indian J Med Res"},{"issue":"2","key":"10.1016\/j.biotechadv.2012.03.004_bb0425","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1086\/505121","article-title":"Clinical features in children hospitalized during the 2005 epidemic of Japanese encephalitis in Uttar Pradesh, India","volume":"43","author":"Kumar","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.biotechadv.2012.03.004_bb0430","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev.micro.62.081307.163005","article-title":"Global spread and persistence of dengue","volume":"62","author":"Kyle","year":"2008","journal-title":"Annu Rev Microbiol"},{"issue":"1","key":"10.1016\/j.biotechadv.2012.03.004_bb0995","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1478-7954-9-1","article-title":"Measuring the burden of arboviral diseases: the spectrum of morbidity and mortality from four prevalent infections","volume":"9","author":"Labeaud","year":"2011","journal-title":"Popul Health Metr"},{"issue":"11","key":"10.1016\/j.biotechadv.2012.03.004_bb0440","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0198-8859(02)00682-1","article-title":"HLA-DR antigen frequencies in Mexican patients with dengue virus infection: HLA-DR4 as a possible genetic resistance factor for dengue hemorrhagic fever","volume":"63","author":"LaFleur","year":"2002","journal-title":"Hum Immunol"},{"issue":"1","key":"10.1016\/j.biotechadv.2012.03.004_bb0445","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1467-7652.2011.00649.x","article-title":"Robust production of virus-like particles and monoclonal antibodies with geminiviral replicon vectors in lettuce","volume":"10","author":"Lai","year":"2011","journal-title":"Plant Biotechnol J"},{"issue":"30","key":"10.1016\/j.biotechadv.2012.03.004_bb0450","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1016\/j.vaccine.2005.03.006","article-title":"A recombinant envelope protein vaccine against West Nile virus","volume":"23","author":"Ledizet","year":"2005","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.biotechadv.2012.03.004_bb0455","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.1128\/JVI.02509-07","article-title":"E protein domain III determinants of yellow fever virus 17D vaccine strain enhance binding to glycosaminoglycans, impede virus spread, and attenuate virulence","volume":"82","author":"Lee","year":"2008","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.biotechadv.2012.03.004_bb0460","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.nano.2006.07.009","article-title":"Adaptations of nanoscale viruses and other protein cages for medical applications","volume":"2","author":"Lee","year":"2006","journal-title":"Nanomedicine"},{"issue":"5","key":"10.1016\/j.biotechadv.2012.03.004_bb0465","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.vaccine.2006.09.014","article-title":"Evaluation of vaccine Encepur Adult for induction of human neutralizing antibodies against recent Far Eastern subtype strains of tick-borne encephalitis virus","volume":"25","author":"Leonova","year":"2007","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.biotechadv.2012.03.004_bb0470","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.vaccine.2006.08.018","article-title":"Preparation and immunogenic properties of a recombinant West Nile subunit vaccine","volume":"25","author":"Lieberman","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.biotechadv.2012.03.004_bb0475","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10529-007-9529-9","article-title":"Protective immunity of E. coli-synthesized NS1 protein of Japanese encephalitis virus","volume":"30","author":"Lin","year":"2008","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.biotechadv.2012.03.004_bb2010","series-title":"Fields Virology","first-page":"1101","article-title":"Flaviviridae: the viruses and their replication","author":"Lindenbach","year":"2007"},{"issue":"1","key":"10.1016\/j.biotechadv.2012.03.004_bb0480","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11262-009-0418-2","article-title":"Recombinant dengue virus-like particles from Pichia pastoris: efficient production and immunological properties","volume":"40","author":"Liu","year":"2010","journal-title":"Virus Genes"},{"issue":"43","key":"10.1016\/j.biotechadv.2012.03.004_bb0485","doi-asserted-by":"crossref","first-page":"7307","DOI":"10.1016\/j.vaccine.2011.07.089","article-title":"Prevention of tick-borne encephalitis by FSME-IMMUN((R)) vaccines: review of a clinical development programme","volume":"29","author":"Loew-Baselli","year":"2011","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.biotechadv.2012.03.004_bb0490","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1128\/JVI.77.7.4370-4382.2003","article-title":"Intracellular assembly and secretion of recombinant subviral particles from tick-borne encephalitis virus","volume":"77","author":"Lorenz","year":"2003","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.biotechadv.2012.03.004_bb0495","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nrg1177","article-title":"The production of recombinant pharmaceutical proteins in plants","volume":"4","author":"Ma","year":"2003","journal-title":"Nat Rev Genet"},{"issue":"18","key":"10.1016\/j.biotechadv.2012.03.004_bb0500","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1073\/pnas.0400149101","article-title":"In planta engineering of viral RNA replicons: efficient assembly by recombination of DNA modules delivered by Agrobacterium","volume":"101","author":"Marillonnet","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.biotechadv.2012.03.004_bb0505","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nbt1094","article-title":"Systemic Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient transient expression in plants","volume":"23","author":"Marillonnet","year":"2005","journal-title":"Nat Biotechnol"},{"issue":"9276","key":"10.1016\/j.biotechadv.2012.03.004_bb0510","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","article-title":"Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases","volume":"358","author":"Martin","year":"2001","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.biotechadv.2012.03.004_bb0515","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.vaccine.2007.10.055","article-title":"Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus","volume":"26","author":"Martina","year":"2008","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.biotechadv.2012.03.004_bb0525","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s10529-010-0236-6","article-title":"Exploring different strategies to express Dengue virus envelope protein in a plant system","volume":"32","author":"Martinez","year":"2010","journal-title":"Biotechnol Lett"},{"issue":"1","key":"10.1016\/j.biotechadv.2012.03.004_bb0520","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11240-011-9960-4","article-title":"Expression of a KDEL-tagged dengue virus protein in cell suspension cultures of Nicotiana tabacum and Morinda citrifolia","volume":"107","author":"Martinez","year":"2011","journal-title":"Plant Cell Tissue Organ Cult"},{"issue":"5","key":"10.1016\/j.biotechadv.2012.03.004_bb0530","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4269\/ajtmh.2008.79.678","article-title":"Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity","volume":"79","author":"McArthur","year":"2008","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.biotechadv.2012.03.004_bb0535","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1586\/14760584.4.4.553","article-title":"Yellow fever vaccine","volume":"4","author":"Monath","year":"2005","journal-title":"Expert Rev Vaccines"},{"issue":"22","key":"10.1016\/j.biotechadv.2012.03.004_bb0540","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1056\/NEJMp0707161","article-title":"Dengue and yellow fever\u2014challenges for the development and use of vaccines","volume":"357","author":"Monath","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.biotechadv.2012.03.004_bb0545","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.antiviral.2007.10.009","article-title":"Treatment of yellow fever","volume":"78","author":"Monath","year":"2008","journal-title":"Antiviral Res"},{"issue":"8","key":"10.1016\/j.biotechadv.2012.03.004_bb0555","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1086\/378356","article-title":"Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen","volume":"188","author":"Monath","year":"2003","journal-title":"J Infect Dis"},{"issue":"17","key":"10.1016\/j.biotechadv.2012.03.004_bb0565","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1073\/pnas.0601932103","article-title":"A live, attenuated recombinant West Nile virus vaccine","volume":"103","author":"Monath","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"10.1016\/j.biotechadv.2012.03.004_bb0550","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMoa1009303","article-title":"An inactivated cell-culture vaccine against yellow fever","volume":"364","author":"Monath","year":"2011","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.biotechadv.2012.03.004_bb0560","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1016\/j.vaccine.2010.03.023","article-title":"Inactivated yellow fever 17D vaccine: development and nonclinical safety, immunogenicity and protective activity","volume":"28","author":"Monath","year":"2011","journal-title":"Vaccine"},{"issue":"6996","key":"10.1016\/j.biotechadv.2012.03.004_bb0570","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature02759","article-title":"The challenge of emerging and re-emerging infectious diseases","volume":"430","author":"Morens","year":"2004","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.biotechadv.2012.03.004_bb0575","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1007\/s00705-003-0167-9","article-title":"Carboxy-terminally truncated Dengue 4 virus envelope glycoprotein expressed in Pichia pastoris induced neutralizing antibodies and resistance to Dengue 4 virus challenge in mice","volume":"148","author":"Mune","year":"2003","journal-title":"Arch Virol"},{"key":"10.1016\/j.biotechadv.2012.03.004_bb0580","first-page":"195","article-title":"The ecology and epidemiology of West Nile virus in Africa, Europe and Asia","volume":"267","author":"Murgue","year":"2002","journal-title":"Curr Top Microbiol Immunol"},{"issue":"2","key":"10.1016\/j.biotechadv.2012.03.004_bb0585","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.biotechadv.2010.11.008","article-title":"Review of dengue virus and the development of a vaccine","volume":"29","author":"Murrell","year":"2011","journal-title":"Biotechnol Adv"},{"issue":"20","key":"10.1016\/j.biotechadv.2012.03.004_bb0590","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1016\/j.vaccine.2003.12.008","article-title":"Japanese encephalitis subunit vaccine composed of virus-like envelope antigen particles purified from serum-free medium of a high-producer J12#26 cell clone","volume":"22","author":"Mutoh","year":"2004","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.biotechadv.2012.03.004_bb1000","doi-asserted-by":"crossref","first-page":"e304","DOI":"10.1371\/journal.pntd.0000304","article-title":"Protective and enhancing HLA alleles, HLA-DRB1*0901 and HLA-A*24, for severe forms of dengue virus infection, dengue hemorrhagic fever and dengue shock syndrome","volume":"2","author":"Nguyen","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"10.1016\/j.biotechadv.2012.03.004_bb0600","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0966-842X(03)00208-7","article-title":"Virus-like particles as immunogens","volume":"11","author":"Noad","year":"2003","journal-title":"Trends Microbiol"},{"issue":"40","key":"10.1016\/j.biotechadv.2012.03.004_bb0605","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1016\/j.vaccine.2010.07.055","article-title":"Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate","volume":"28","author":"Ohtaki","year":"2010","journal-title":"Vaccine"},{"issue":"37","key":"10.1016\/j.biotechadv.2012.03.004_bb0610","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1016\/j.vaccine.2005.04.044","article-title":"Financial requirements of immunisation programmes in developing countries: a 2004\u20132014 perspective","volume":"23","author":"Peny","year":"2005","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.biotechadv.2012.03.004_bb0615","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.tmaid.2010.08.001","article-title":"Tick-borne encephalitis (TBE) trends in epidemiology and current and future management","volume":"8","author":"Petri","year":"2010","journal-title":"Travel Med Infect Dis"},{"issue":"1","key":"10.1016\/j.biotechadv.2012.03.004_bb0620","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0042-6822(03)00450-1","article-title":"Molecularly engineered live-attenuated chimeric West Nile\/dengue virus vaccines protect rhesus monkeys from West Nile virus","volume":"314","author":"Pletnev","year":"2003","journal-title":"Virology"},{"issue":"10","key":"10.1016\/j.biotechadv.2012.03.004_bb0625","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1002\/jmv.21587","article-title":"Safety evaluation of chimeric Langat\/Dengue 4 flavivirus, a live vaccine candidate against tick-borne encephalitis","volume":"81","author":"Pripuzova","year":"2009","journal-title":"J Med Virol"},{"issue":"5\u20136","key":"10.1016\/j.biotechadv.2012.03.004_bb0635","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0020-7519(03)00063-8","article-title":"Traditional and novel approaches to flavivirus vaccines","volume":"33","author":"Pugachev","year":"2003","journal-title":"Int J Parasitol"},{"issue":"5","key":"10.1016\/j.biotechadv.2012.03.004_bb0630","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/01.qco.0000178823.28585.ad","article-title":"New developments in flavivirus vaccines with special attention to yellow fever","volume":"18","author":"Pugachev","year":"2005","journal-title":"Curr Opin Infect Dis"},{"issue":"4","key":"10.1016\/j.biotechadv.2012.03.004_bb2005","first-page":"409","article-title":"The development of flavivirus vaccines","volume":"9","author":"Pulmanausahakul","year":"2010","journal-title":"Afr J Biotechnol"},{"issue":"1","key":"10.1016\/j.biotechadv.2012.03.004_bb0640","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-5793(98)01599-3","article-title":"Hepatitis B core particles as a universal display model: a structure-function basis for development","volume":"442","author":"Pumpens","year":"1999","journal-title":"FEBS Lett"},{"issue":"2","key":"10.1016\/j.biotechadv.2012.03.004_bb0645","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.virol.2004.12.036","article-title":"Secretion of noninfectious dengue virus-like particles and identification of amino acids in the stem region involved in intracellular retention of envelope protein","volume":"333","author":"Purdy","year":"2005","journal-title":"Virology"},{"issue":"Pt 8","key":"10.1016\/j.biotechadv.2012.03.004_bb0650","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1099\/0022-1317-71-8-1697","article-title":"Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus non-structural proteins, NS1, NS2a and NS2b","volume":"71","author":"Putnak","year":"1990","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.biotechadv.2012.03.004_bb0655","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4269\/ajtmh.1991.45.159","article-title":"Dengue-1 virus envelope glycoprotein gene expressed in recombinant baculovirus elicits virus-neutralizing antibody in mice and protects them from virus challenge","volume":"45","author":"Putnak","year":"1991","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"10.1016\/j.biotechadv.2012.03.004_bb0660","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1086\/425933","article-title":"Induction of sterilizing immunity against West Nile Virus (WNV), by immunization with WNV-like particles produced in insect cells","volume":"190","author":"Qiao","year":"2004","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.biotechadv.2012.03.004_bb0665","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.antiviral.2010.02.313","article-title":"A high-throughput assay using dengue-1 virus-like particles for drug discovery","volume":"86","author":"Qing","year":"2011","journal-title":"Antiviral Res"},{"issue":"14","key":"10.1016\/j.biotechadv.2012.03.004_bb0670","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.micinf.2004.08.010","article-title":"Oral immunization of mice with Japanese encephalitis virus envelope protein synthesized in Escherichia coli induces anti-viral antibodies","volume":"6","author":"Rauthan","year":"2004","journal-title":"Microbes Infect"},{"issue":"1","key":"10.1016\/j.biotechadv.2012.03.004_bb0675","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1467-7652.2009.00462.x","article-title":"High level protein expression in plants through the use of a novel autonomously replicating geminivirus shuttle vector","volume":"8","author":"Regnard","year":"2010","journal-title":"Plant Biotechnol J"},{"issue":"5","key":"10.1016\/j.biotechadv.2012.03.004_bb0680","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1586\/14760584.7.5.589","article-title":"Advances in vaccination against tick-borne encephalitis","volume":"7","author":"Rendi-Wagner","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"6529","key":"10.1016\/j.biotechadv.2012.03.004_bb0685","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/375291a0","article-title":"The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution","volume":"375","author":"Rey","year":"1995","journal-title":"Nature"},{"issue":"4715","key":"10.1016\/j.biotechadv.2012.03.004_bb0690","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1126\/science.4023707","article-title":"Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution","volume":"229","author":"Rice","year":"1985","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.biotechadv.2012.03.004_bb0695","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3201\/eid0705.017524","article-title":"Wind-blown mosquitoes and introduction of Japanese encephalitis into Australia","volume":"7","author":"Ritchie","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.biotechadv.2012.03.004_bb0700","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1467-7652.2010.00507.x","article-title":"Plant-made vaccines for humans and animals","volume":"8","author":"Rybicki","year":"2010","journal-title":"Plant Biotechnol J"},{"issue":"2","key":"10.1016\/j.biotechadv.2012.03.004_bb0705","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jinf.2004.10.005","article-title":"Acute flaccid paralysis: the spectrum of a newly recognized complication of West Nile virus infection","volume":"51","author":"Saad","year":"2005","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.biotechadv.2012.03.004_bb0710","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4269\/ajtmh.2002.66.264","article-title":"Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses","volume":"66","author":"Sabchareon","year":"2002","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.biotechadv.2012.03.004_bb0720","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1263\/jbb.102.333","article-title":"Enhancement of recombinant soluble dengue virus 2 envelope domain III protein production in Escherichia coli trxB and gor double mutant","volume":"102","author":"Saejung","year":"2006","journal-title":"J Biosci Bioeng"},{"issue":"36","key":"10.1016\/j.biotechadv.2012.03.004_bb0715","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1016\/j.vaccine.2007.06.029","article-title":"Production of dengue 2 envelope domain III in plant using TMV-based vector system","volume":"25","author":"Saejung","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.biotechadv.2012.03.004_bb0725","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ymeth.2006.05.020","article-title":"Virus-like particles production in green plants","volume":"40","author":"Santi","year":"2006","journal-title":"Methods"},{"issue":"9","key":"10.1016\/j.biotechadv.2012.03.004_bb1005","doi-asserted-by":"crossref","first-page":"e24505","DOI":"10.1371\/journal.pone.0024505","article-title":"Pre-clinical efficacy and safety of experimental vaccines based on non-replicating vaccinia vectors against yellow fever","volume":"6","author":"Schafer","year":"2011","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.biotechadv.2012.03.004_bb0735","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1128\/JVI.70.7.4549-4557.1996","article-title":"Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions","volume":"70","author":"Schalich","year":"1996","journal-title":"J Virol"},{"issue":"1\u20133","key":"10.1016\/j.biotechadv.2012.03.004_bb0740","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0168-1656(95)00118-2","article-title":"Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. Presentation of foreign epitopes","volume":"44","author":"Schodel","year":"1996","journal-title":"J Biotechnol"},{"issue":"21","key":"10.1016\/j.biotechadv.2012.03.004_bb0745","doi-asserted-by":"crossref","first-page":"11605","DOI":"10.1128\/JVI.78.21.11605-11614.2004","article-title":"Trans-packaged West Nile virus-like particles: infectious properties in vitro and in infected mosquito vectors","volume":"78","author":"Scholle","year":"2004","journal-title":"J Virol"},{"issue":"9426","key":"10.1016\/j.biotechadv.2012.03.004_bb0750","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(04)16459-3","article-title":"Live flavivirus vaccines: reasons for caution","volume":"363","author":"Seligman","year":"2004","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.biotechadv.2012.03.004_bb0755","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.biotechadv.2009.05.009","article-title":"Foreign protein production using plant cell and organ cultures: advantages and limitations","volume":"27","author":"Shih","year":"2009","journal-title":"Biotechnol Adv"},{"issue":"9","key":"10.1016\/j.biotechadv.2012.03.004_bb0760","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.vaccine.2007.12.047","article-title":"Induction of neutralizing antibodies against dengue virus type 2 upon mucosal administration of a recombinant Lactococcus lactis strain expressing envelope domain III antigen","volume":"26","author":"Sim","year":"2008","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.biotechadv.2012.03.004_bb0765","doi-asserted-by":"crossref","first-page":"9577","DOI":"10.1128\/JVI.00284-06","article-title":"Characterization of antibody responses to combinations of a dengue virus type 2 DNA vaccine and two dengue virus type 2 protein vaccines in rhesus macaques","volume":"80","author":"Simmons","year":"2006","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.biotechadv.2012.03.004_bb0770","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/bit.10444","article-title":"Hepatitis B surface antigen (HBsAg) expression in plant cell culture: kinetics of antigen accumulation in batch culture and its intracellular form","volume":"80","author":"Smith","year":"2002","journal-title":"Biotechnol Bioeng"},{"issue":"2","key":"10.1016\/j.biotechadv.2012.03.004_bb0780","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1053\/jinf.2001.0802","article-title":"Dengue and other emerging flaviviruses","volume":"42","author":"Solomon","year":"2001","journal-title":"J Infect"},{"issue":"4","key":"10.1016\/j.biotechadv.2012.03.004_bb0775","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/jnnp.68.4.405","article-title":"Japanese encephalitis","volume":"68","author":"Solomon","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.biotechadv.2012.03.004_bb0785","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1743-422X-7-146","article-title":"A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice","volume":"7","author":"Spohn","year":"2010","journal-title":"Virol J"},{"issue":"RR-7","key":"10.1016\/j.biotechadv.2012.03.004_bb1010","first-page":"1","article-title":"Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Staples","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"17\u201318","key":"10.1016\/j.biotechadv.2012.03.004_bb0795","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/S0264-410X(97)00128-X","article-title":"Affinity-purified dengue-2 virus envelope glycoprotein induces neutralizing antibodies and protective immunity in mice","volume":"15","author":"Staropoli","year":"1997","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.biotechadv.2012.03.004_bb0800","first-page":"308","article-title":"Understanding dengue pathogenesis: implications for vaccine design","volume":"83","author":"Stephenson","year":"2005","journal-title":"Bull World Health Organ"},{"issue":"1","key":"10.1016\/j.biotechadv.2012.03.004_bb0805","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1467-7652.2006.00216.x","article-title":"Approaches to achieve high-level heterologous protein production in plants","volume":"5","author":"Streatfield","year":"2007","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.biotechadv.2012.03.004_bb0810","first-page":"135","article-title":"Bioreactor engineering for recombinant protein production using plant cell suspension culture","volume":"6","author":"Su","year":"2006","journal-title":"Plant Tissue Culture Engineering"},{"issue":"1\u20132","key":"10.1016\/j.biotechadv.2012.03.004_bb0815","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0166-0934(97)00151-1","article-title":"The production of recombinant dengue virus E protein using Escherichia coli and Pichia pastoris","volume":"69","author":"Sugrue","year":"1997","journal-title":"J Virol Methods"},{"issue":"Pt 8","key":"10.1016\/j.biotechadv.2012.03.004_bb0820","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1099\/0022-1317-78-8-1861","article-title":"Expression of the dengue virus structural proteins in Pichia pastoris leads to the generation of virus-like particles","volume":"78","author":"Sugrue","year":"1997","journal-title":"J Gen Virol"},{"issue":"6 Suppl","key":"10.1016\/j.biotechadv.2012.03.004_bb0835","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4269\/ajtmh.2003.69.6_suppl.0690024","article-title":"Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidates","volume":"69","author":"Sun","year":"2003","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.biotechadv.2012.03.004_bb0830","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4161\/hv.5.1.6348","article-title":"Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naive adults","volume":"5","author":"Sun","year":"2009","journal-title":"Hum Vaccin"},{"issue":"2","key":"10.1016\/j.biotechadv.2012.03.004_bb1015","doi-asserted-by":"crossref","first-page":"e31434","DOI":"10.1371\/journal.pone.0031434","article-title":"Comprehensive mapping of common immunodominant epitopes in the west Nile virus nonstructural protein 1 recognized by avian antibody responses","volume":"7","author":"Sun","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biotechadv.2012.03.004_bb0840","doi-asserted-by":"crossref","first-page":"781712","DOI":"10.1155\/2009\/781712","article-title":"Virus-specific read-through codon preference affects infectivity of chimeric cucumber green mottle mosaic viruses displaying a dengue virus epitope","volume":"2009","author":"Teoh","year":"2009","journal-title":"J Biomed Biotechnol"},{"issue":"6","key":"10.1016\/j.biotechadv.2012.03.004_bb0845","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1084\/jem.65.6.787","article-title":"The use of Yellow Fever Virus modified by in vitro cultivation for human immunization","volume":"65","author":"Theiler","year":"1937","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.biotechadv.2012.03.004_bb0850","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/clind\/16.2.295","article-title":"Nutritional status of children with dengue hemorrhagic fever","volume":"16","author":"Thisyakorn","year":"1993","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.biotechadv.2012.03.004_bb0855","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.biotechadv.2009.03.006","article-title":"Plants as bioreactors for the production of vaccine antigens","volume":"27","author":"Tiwari","year":"2009","journal-title":"Biotechnol Adv"},{"issue":"12","key":"10.1016\/j.biotechadv.2012.03.004_bb0860","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.tibtech.2003.10.002","article-title":"Molecular farming in plants: host systems and expression technology","volume":"21","author":"Twyman","year":"2003","journal-title":"Trends Biotechnol"},{"issue":"9276","key":"10.1016\/j.biotechadv.2012.03.004_bb0865","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(01)05326-0","article-title":"Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases","volume":"358","author":"Vasconcelos","year":"2001","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biotechadv.2012.03.004_bb0870","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/315215","article-title":"Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity","volume":"181","author":"Vaughn","year":"2000","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.biotechadv.2012.03.004_bb0875","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.2174\/092986609789353709","article-title":"Antibodies against refolded recombinant envelope protein (domain III) of Japanese encephalitis virus inhibit the JEV infection to Porcine Stable Kidney cells","volume":"16","author":"Verma","year":"2009","journal-title":"Protein Pept Lett"},{"issue":"27\u201328","key":"10.1016\/j.biotechadv.2012.03.004_bb0880","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1016\/j.vaccine.2006.04.068","article-title":"Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18","volume":"24","author":"Villa","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.biotechadv.2012.03.004_bb0885","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.virol.2009.09.001","article-title":"Structure of yellow fever virus envelope protein domain III","volume":"394","author":"Volk","year":"2009","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.biotechadv.2012.03.004_bb0890","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.bbrc.2009.01.061","article-title":"Generation and immunogenicity of Japanese encephalitis virus envelope protein expressed in transgenic rice","volume":"380","author":"Wang","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"16","key":"10.1016\/j.biotechadv.2012.03.004_bb0895","doi-asserted-by":"crossref","first-page":"8702","DOI":"10.1128\/JVI.77.16.8702-8711.2003","article-title":"Oral immunogenicity of human papillomavirus-like particles expressed in potato","volume":"77","author":"Warzecha","year":"2003","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.biotechadv.2012.03.004_bb0900","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S1473-3099(09)70254-3","article-title":"Progress towards a dengue vaccine","volume":"9","author":"Webster","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"9188","key":"10.1016\/j.biotechadv.2012.03.004_bb0905","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/S0140-6736(99)00236-6","article-title":"Variation in virulence of dengue virus","volume":"354","author":"White","year":"1999","journal-title":"Lancet"},{"issue":"34\/35","key":"10.1016\/j.biotechadv.2012.03.004_bb1020","first-page":"325","article-title":"Japanese encephalitis virus vaccines","volume":"81","author":"WHO","year":"2006","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.biotechadv.2012.03.004_bb2000","first-page":"1","article-title":"Guidelines for the clinical evaluation of dengue vaccines in endemic areas","author":"WHO","year":"2008","journal-title":"Immunization, vaccines and biological"},{"issue":"4","key":"10.1016\/j.biotechadv.2012.03.004_bb0915","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.tmaid.2010.05.007","article-title":"Tick borne encephalitis TBE\u2014vaccination in non-endemic countries","volume":"8","author":"Wiedermann","year":"2010","journal-title":"Travel Med Infect Dis"},{"issue":"43","key":"10.1016\/j.biotechadv.2012.03.004_bb0920","doi-asserted-by":"crossref","first-page":"7456","DOI":"10.1016\/j.vaccine.2011.07.054","article-title":"Novel formulations enhance the thermal stability of live-attenuated flavivirus vaccines","volume":"29","author":"Wiggan","year":"2011","journal-title":"Vaccine"},{"issue":"Suppl. 1","key":"10.1016\/j.biotechadv.2012.03.004_bb1025","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.1111\/j.1749-6632.2009.05057.x","article-title":"A mouse model for studying dengue virus pathogenesis and immune response","volume":"1171","author":"Williams","year":"2009","journal-title":"Ann N Y Acad Sci"},{"issue":"5\u20136","key":"10.1016\/j.biotechadv.2012.03.004_bb0930","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.vaccine.2003.02.001","article-title":"Sub-fragments of the envelope gene are highly protective against the Japanese encephalitis virus lethal infection in DNA priming-protein boosting immunization strategies","volume":"22","author":"Wu","year":"2004","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.biotechadv.2012.03.004_bb0935","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.biotechadv.2011.08.020","article-title":"Green factory: Plants as bioproduction platforms for recombinant proteins","volume":"30","author":"Xu","year":"2012","journal-title":"Biotechnol Adv"},{"issue":"7","key":"10.1016\/j.biotechadv.2012.03.004_bb0940","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrd3499","article-title":"Bio-inspired, bioengineered and biomimetic drug delivery carriers","volume":"10","author":"Yoo","year":"2011","journal-title":"Nat Rev Drug Discov"},{"issue":"Suppl. 37","key":"10.1016\/j.biotechadv.2012.03.004_bb1030","first-page":"134","article-title":"TBE booster immunization in adults\u2014first experience with a new tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer","volume":"293","author":"Zent","year":"2004","journal-title":"Int J Med Microbiol"},{"issue":"3\u20134","key":"10.1016\/j.biotechadv.2012.03.004_bb1035","first-page":"43","article-title":"New TBE vaccine formulations\u2014free of proteineous stabilizer and preservatives. Overview of clinical studies and first year post-marketing experience","volume":"146","author":"Zent","year":"2004","journal-title":"MMW Fortschr Med"},{"issue":"9","key":"10.1016\/j.biotechadv.2012.03.004_bb0965","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.str.2004.06.019","article-title":"Conformational changes of the flavivirus E glycoprotein","volume":"12","author":"Zhang","year":"2004","journal-title":"Structure"},{"key":"10.1016\/j.biotechadv.2012.03.004_bb0955","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1743-422X-4-17","article-title":"Expression of particulate-form of Japanese encephalitis virus envelope protein in a stably transfected Drosophila cell line","volume":"4","author":"Zhang","year":"2007","journal-title":"Virol J"},{"issue":"2","key":"10.1016\/j.biotechadv.2012.03.004_bb0970","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jviromet.2007.02.012","article-title":"High-level expression of recombinant dengue virus type 2 envelope domain III protein and induction of neutralizing antibodies in BALB\/C mice","volume":"143","author":"Zhang","year":"2007","journal-title":"J Virol Methods"},{"key":"10.1016\/j.biotechadv.2012.03.004_bb0960","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/1743-422X-8-333","article-title":"Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice","volume":"8","author":"Zhang","year":"2011","journal-title":"Virol J"}],"container-title":["Biotechnology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0734975012000705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0734975012000705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T23:26:58Z","timestamp":1593905218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0734975012000705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":198,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0734975012000705"],"URL":"https:\/\/doi.org\/10.1016\/j.biotechadv.2012.03.004","relation":{},"ISSN":["0734-9750"],"issn-type":[{"value":"0734-9750","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}